In ovarian cancer, with over-expression of SYTL2 (synaptotagmin like 2) mRNA, the methylation rate in specific CpG sites of the SYTL2 promoter decreased, which significantly promoted migration and invasion of ovarian cancer cells (41). The gene discussed is SYTL2; the disease is ovarian carcinoma.